The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease

Pediatric Allergy and Immunology

Volumn 18, Issue 4, 2007, Pages 354-359

  Kuo, Ho Chang ^a   Yang, Kuender D ^a   Liang, Chi Di ^a   Bong, Chin Nam ^b   Yu, Hong Ren ^a   Wang, Lin ^a   Wang, Chih Lu ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^c Po Jen Hospital   (Taiwan)

Author keywords

Eosinophils; Intravenous immunoglobulin resistance; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ACUTE DISEASE; ARTICLE; CHILD; DISEASE COURSE; DRUG TREATMENT FAILURE; EOSINOPHIL; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPOALBUMINEMIA; IMMUNOPATHOGENESIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT OUTCOME;

CHILD; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 34250710066     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2007.00516.x     Document Type: Article

References (25)

1. Kawasaki T, Kosaki F, Osawa S, Shigemitsu I, Yanagawa S. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974 : 54 : 271 6.
2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004 : 110 : 2747 71.
3. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986 : 315 : 341 7.
4. Newburger JW, Takahashi M, Beiser AS, et al. A single infusion of intravenous gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991 : 324 : 1633 9.
5. Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 1993 : 123 : 657 9.
6. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gamma globulin treatment failure in Kawasaki disease. Pediatrics 2000 : 105 : e78.
7. Fukunishi M, Kikkawa M, Hamana K, et al. Prediction of non-responsiveness to intravenous high-dose γ-globulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000 : 137 : 172 6.
8. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978 : 61 : 100 7.
9. Gear JH, Meyers KE, Steele M. Kawasaki disease manifesting with acute cholangitis: a case report. S Afr Med J 1992 : 81 : 31 3.
10. Terai M, Yasukawa K, Honda T, et al. Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr Infect Dis J 2002 : 21 : 777 80.
11. Wang CL, Wu YT, Lee CJ, Liu HC, Huang LT, Yang KD. Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2002 : 141 : 560 5.
12. Hsu YH, Wang YH, Hsu WY, Lee YP. Kawasaki disease characterized by erythema and induration at the Bacillus Calmette-Guerin and purified protein derivative inoculation sites. Pediatr Infect Dis J 1987 : 6 : 576 8.
13. Chang RK. Hospitalizations for Kawasaki disease among children in the United States, 1988-97. Pediatrics 2002 : 109 : e87.
14. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001 : 107 : e33.
15. Harnden A, Alves B, Sheikh A. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. Br Med J 2002 : 324 : 1424 5.
16. Du ZD, Zhang T, Liang L, et al. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatr Infect Dis J 2002 : 21 : 103 10.
17. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and re-treatment in Kawasaki disease. Pediatr Infect Dis J 1998 : 17 : 1144 8.
18. Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 2003 : 24 : 145 8.
19. Morikawa Y, Ohashi Y, Harada K, et al. Coronary risks after high-dose gamma-globulin in children with Kawasaki disease. Pediatr Int 2000 : 42 : 464 9.
20. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous γ-globulin treatment in Kawasaki disease. J Pediatr 2000 : 137 : 177 80.
21. Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. Am J Cardiol 1998 : 81 : 1116 20.
22. Schleimer RP, Brochner BS. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994 : 94 : 1202 13.
23. Rothenberg ME. Mechanism of diseases: eosinophilia. N Engl J Med 1998 : 338 : 1592 600.
24. Mayatepek E, Lehmann WD. Increased generation of cysteinyl leukotrienes in Kawasaki disease. Arch Dis Child 1995 : 72 : 526 7.
25. Saito K, Nagata M, Kikuchi I, Sakamoto Y. Leukotriene D4 and eosinophil transendothelial migration, superoxide generation, and degranulation via beta2 integrin. Ann Allergy Asthma Immunol 2004 : 93 : 594 600.